RE:RE:RE:RE:“Second mouse gets the cheese “Correction: BioNTech / Genentech's Phase 2 mRNA "vaccine" clinical trial involving adjuvant autogene cevumeran in combination with the anti-PD-L1 immune checkpoint inhibitor atezolizumab and chemotherapy is randomized to mFOLFIRINOX. Excuse my oversight, however everything else regarding DFS as the primary endpoint applies.